2016
DOI: 10.1097/md.0000000000004780
|View full text |Cite
|
Sign up to set email alerts
|

Renal artery stent in solitary functioning kidneys

Abstract: Background:Solitary functioning kidney (SFK) is tough issue to address in clinical, mostly developed from renal artery stenosis (RAS) in adults. Although renal artery stent is widely used to help SFK patients, the efficacy of the stent is still disputable. This study is aimed at reviewing a series of SFK cases to draw a conclusion about the efficacy of renal artery stent.Methods:All related papers published in PubMed, Web of Science, EMBASE, and Cochrane Library were searched. Studies or subsets were included … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 29 publications
0
9
0
Order By: Relevance
“…When revascularization is considered, first-line treatment is angioplasty with stent placement, as angioplasty alone shows higher prevalence of restenosis with similar outcomes. 1,21,24,28,29 Major complications of stenting are specialist-and lesion-dependant; they occur in less than 5% of the cases and include bleeding, pseudoaneurysms, distal embolisation, acute kidney injury and acute renal artery occlusion or dissection, sometimes resulting in terminal renal replacement. 7,9,21,30 Interestingly, a systematic literature review made by Ma et al 21 concerning patients with a solitary functioning kidney concluded that up to 77% of the patients with a single-functioning kidney showed an improvement or stabilisation of their renal function after PTRA.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…When revascularization is considered, first-line treatment is angioplasty with stent placement, as angioplasty alone shows higher prevalence of restenosis with similar outcomes. 1,21,24,28,29 Major complications of stenting are specialist-and lesion-dependant; they occur in less than 5% of the cases and include bleeding, pseudoaneurysms, distal embolisation, acute kidney injury and acute renal artery occlusion or dissection, sometimes resulting in terminal renal replacement. 7,9,21,30 Interestingly, a systematic literature review made by Ma et al 21 concerning patients with a solitary functioning kidney concluded that up to 77% of the patients with a single-functioning kidney showed an improvement or stabilisation of their renal function after PTRA.…”
Section: Discussionmentioning
confidence: 99%
“… 9 13 In acute settings with rapidly progressive heart and renal failure, BMT versus revascularisation has been only rarely studied and some observational studies have shown improved outcomes in patients who underwent percutaneous transluminal renal angioplasty (PTRA) and stenting of the RAS. 13 20 Indeed, some subgroups of patients, including patients with a solitary functioning kidney, 20 23 could benefit from this more interventional approach.…”
Section: Introductionmentioning
confidence: 99%
“…Additionally, renal events resulted from diabetes, nephritis, nephropathy, heart failure, and a solitary functioning kidney. In a previous meta-analysis, 39 7 studies focused on the efficacy of PTRA on patients with a solitary functioning kidney, involving 253 cases. This previous meta-analysis showed that a renal artery stent was beneficial for patients with a solitary functioning kidney regarding improved or stabilized renal function.…”
Section: Discussionmentioning
confidence: 99%
“…There have been several studies reporting the benefits of revascularization in high-risk patients with ARAS [8,9,22,24]. Patients presenting with a combination of rapidly declining kidney function and refractory hypertension may benefit from revascularization [22].…”
Section: Discussionmentioning
confidence: 99%
“…Current guidelines for ARAS recommend PTA as a reasonable option for patients with haemodynamically significant RAS with clinical manifestations such as resistant hypertension, unexplained pulmonary edema, or progressive chronic kidney disease [7,8]. However, patient selection for renal revascularization is sometimes challenging, because limited comparative data are available on the specific phenotype of patients who would benefit from the procedure [911].…”
Section: Introductionmentioning
confidence: 99%